1,399
Views
4
CrossRef citations to date
0
Altmetric
Reviews

The impact of micronized progesterone on cardiovascular events – a systematic review

, , ORCID Icon, & ORCID Icon
Pages 327-336 | Received 11 Jul 2021, Accepted 10 Dec 2021, Published online: 03 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S. Bontempo, L. Yeganeh, R. Giri & A. J. Vincent. Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis. Climacteric 0:0, pages 1-11.
Read now

Articles from other publishers (3)

Nick Panay, Rossella E. Nappi, Petra Stute, Santiago Palacios, Tomasz Paszkowski, Risa Kagan, David F. Archer, Julie Héroux & Mitra Boolell. (2023) Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice. Maturitas 172, pages 23-31.
Crossref
Guy Morris & Vikram Talaulikar. (2022) Hormone replacement therapy in women with history of thrombosis or a thrombophilia. Post Reproductive Health 29:1, pages 33-41.
Crossref
S. V. Mironova & N. A. Koziolova. (2022) The use of menopausal hormone therapy in women at high cardiovascular risk. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 28:4, pages 357-375.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.